Advancing Oncology Research Through
by Eric RubinREAD ERIC’S PERSPECTIVE
Eight different approved medicines and supportive care therapies that treat more than 12 different cancer types
An oncology development program that includes more than 700 clinical trials ongoing and a pipeline of multiple novel mechanisms in pre-clinical and early phase development
Partnerships with more than 40 companies or research institutions on our clinical research
We believe in the work we do and are working with the entire cancer community to help people with cancer and their caregivers better navigate their journeys.
Ultimately, our work in changing the outcomes of cancer would not be possible without: …the participation of patients in clinical trials
…the support and involvement of the physicians who believe in the importance of advancing the care for patients through innovative clinical trials